Table 1 Study characteristics at the micro-level (sorted by medical domain)
Author (year) | Domain | Patients | Number of patients (I = Intervention, C = Control) | PROM(s) used (GEN = generic, DS = disease-specific) | Overall impact | Quality of study |
|---|---|---|---|---|---|---|
Decision-aid | ||||||
Jayakumar (2021) | Orthopedics | Considering knee replacement for OA | I:69; C:60 | KOOS-JR (DS), PROMIS Global 10 (GEN) | + | Moderate |
Bansback (2022) | Orthopedics | Considering knee replacement for OA | I:82; C:81 | EQ-5D-5L (GEN) | + | Weak |
Volkmann (2015) | Rheumatology | Considering knee replacement for OA | I:111; C:NA | WOMAC (DS) | + | Moderate |
Feedback to patient | ||||||
Ngo (2022) | Gyneacology | Pregnant women | I:89; C:103 | PUQE (DS) | ~ | Moderate |
Rogers (2021) | Oncology | Head-neck cancer, curatively treated | I:140; C:148 | PCI Head Neck Cancer (DS) | + | Moderate |
Steele Gray (2021) | Primary care | Elderly | I:23; C:21 | PROMIS Global Health Scale (GEN), Pain Interference (DS), HAQ (GEN) | ~ | Weak |
Berdal (2023) | Rehabilitation | Rheumatic or musculoskeletal diseases | I:168;C:206 | PSFS (DS), EQ-5D-5L (GEN), EQ VAS (GEN), 30 s sit-to-stand test | ~ | Moderate |
Gossec (2016) | Rheumatology | Reumatoid arthritis | I:159; C:161 | RAPID-3/HAQ2 (GEN), RAID (DS), symptoms as free text | ~ | Moderate |
Feedback to provider | ||||||
Hadjistavropoulos (2009) | Community care | Elderly, with complex medical problems | I:88; C:56 | Pain Assessment Battery (DS), GPM (DS), GDS short form (DS), pain drawing | ~ | Weak |
Almario (2016) | Gastroenterology | Gastrointestinal disease | I:217; C:154 | PROMIS Gastrointestinal (DS) | ~ | Moderate |
Kjaer (2016) | Oncology | Head-neck cancer, finished treatment | I:132; C:134 | HADS (DS), symptoms relevant to head-neck cancer survivors | + | Weak |
Velikova (2004) | Oncology | Any cancer, commencing treatment | I:144, 70; C:72 | EORTC-QLQ-C30 (DS), and HADS (DS) | + | Weak |
Detmar (2002) | Oncology | Any cancer, undergoing palliative chemotherapy | I:114; C:100 | EORTC-QLQ-C30 (DS) | ~ | Weak |
Rosenbloom (2007) | Oncology | Advanced breast, lung or colorectal cancer | I:71, 73; C:69 | FACT-G (DS), including relevant cancer-type subscale | ~ | Strong |
Hilarius (2008) | Oncology | Any cancer, undergoing adjuvant or palliative chemotherapy | I:111; C:108 | EORTC-QLQ-C30 (DS), including relevant cancer-type (breast (QLQ-BR23), colorectal (QLQ- CR38), or lung cancer (QLQ-LC13)) | ~ | Strong |
Barbera (2015) | Oncology | Stage I–III breast cancer, received adjuvant chemotherapy | I:2541; C:5818 | ESAS (DS) | + | Strong |
Patel (2022) | Oncology | Advanced cancer | I:64; C:64 | ESAS (DS) | + | Strong |
Skovlund (2021) | Oncology | Metastic melanoma | I:137; C:142 | EORTC-QLQ-C30 (DS), HADS (DS) | + | Weak |
Ackermans (2017) | Orthopedics | Hip or knee OA | I:72; C:70 | HOOS-PS/KOOS-PS (DS), NRS Pain (DS) | + | Strong |
Holm (2020) | Orthopedics | Hip or knee OA | I:6245; C:N/A | NRS pain (DS), HOOS/KOOS (DS), EQ-5D (GEN), PSFS (DS), physical activity (DS), OA-QI (DS), ASES (DS) | + | Strong |
De Wit (2008) | Pediatrics | Diabetes | I:46; C:45 | PedsQL (GEN), Generic and Diabetes module (DS) | + | Moderate |
Fihn (2004) | Primary care | Veterans | I:5801; C:3218 | SF-36 (GEN), Seattle Outpatient Satisfaction Questionnaire (PREM), 1 of 6 disease-specific questionnaires (Seattle Angina, Seattle Obstructive Lung Disease, Drinking Practices, Seattle Diabetes, Seattle Hypertension, HSCL) | ~ | Weak |
Kroenke (2018) | Primary care | Visiting for any reason | I:151; C:149 | SPADE symptoms (GEN) | ~ | Moderate |
Reiber (2004) | Primary care | Veterans | I:3701; C:2020 | Seattle Diabetes Questionnaire, SF-36 (GEN), SOSQ (PREM) | ~ | Weak |
Richardson (2008) | Primary care | Elderly | I:134; C:131 | Self Report Task Modification and Disability Scale (DS), HUI (GEN), SF-36 (GEN), several physical and functional performance measures | + | Moderate |
Santana (2010) | Pulmonary medicine | Pre- and post-lung transplant | I:108; C:105 | HUI2/3 (GEN) | ~ | Moderate |
Monitoring | ||||||
Davidson (2010) | Cardiology | Myocardial infarction | I:80; C:77 | PHQ-9 (DS) | + | Moderate |
de Jong (2017) | Gastroenterology | IBS | I:465; C:444 | Monitor IBD At Home (DS) | + | Moderate |
Berinstein (2022) | Gastroenterology | IBS | I:100; C:105 | CD-PRO (DS), UC-PRO (DS) | + | Strong |
Cross (2019) | Gastroenterology | IBS | I:115, 116; C:117 | HBI (DS), SSCAI (DS) | + | Moderate |
Pooni (2023) | General surgery | Colorectal surgery | I:128; C:125 | QoR-15 (DS) | + | Strong |
Girgis (2009) | Oncology | Non-localized breast and colorectal cancer | I:120, 119; C:117 | HADS (DS), EORTC-QLQ-C30 (DS), SCNS short form (DS), selected items from the NA-ACP (DS) | ~ | Moderate |
Cooley (2022) | Oncology | Lung cancer | I:89; C:91 | PHQ-9 (DS), SDS (DS), FACT-G (DS), AUDIT (DS), MSAS (DS) | ~ | Weak |
Price (2023) | Oncology | Cancer patients with depression | I:165; C:NA | PHQ-9 (DS) and GAD-2 (DS) | + | Weak |
Livanainen (2023) | Oncology | Colorectal cancer, undergoing chemotherapy | I:36; C:35 | NCTCAE (DS) | ~ | Weak |
Basch (2016) | Oncology | Metastatic breast, genitourinary, gynecologic or lung cancer | I:441; C:325 | NCTCAE (DS) | + | Moderate |
Sharpe (2014) | Oncology | Cancer patients with depression | I:253; C:247 | PHQ-9 (DS) | + | Weak |
Patel (2020) | Oncology | Hematologic or advanced stage cancer | I:186; C:102 | Edmonton Symptom Assessment Scale (DS) | + | Strong |
Maguire (2021) | Oncology | Non-metastatic breast, colorectal, (non-)Hodgkin’s cancer, undergoing chemotherapy | I:415; C:414 | DCTAQ (DS) | + | Strong |
Epstein (2007) | Pediatrics | ADHD | I:162; C:215 | CPRS (DS), CTRS (DS) | ~ | Moderate |
Dobscha (2006) | Primary care | Moderate to severe depression | I:189; C:186 | PHQ-9 (DS) | + | Strong |
Balestrieri (2020) | Primary care | Depression | I:66; C:32 | PHQ-9 (DS) and IDS-SR (DS) | + | Moderate |
Dhingra (2021) | Primary care | Chronic pain | I:256; C:272 | FPS (DS), SBIRT (DS), PHQ-2 (DS), BPI short form (DS), PROMIS Pain Interference short form (DS) | ~ | Weak |
Katon (1996) | Primary care | Depression | I:77; C:76 | BDI short form (DS) | + | Moderate |
Katzelnick (2000) | Primary care | Depression | I:218; C:189 | HAM-D (DS) | + | Moderate |
Unützer (2002) | Primary care | Depression | I:218; C:189 | PHQ-9 (DS) | + | Weak |
Simon (2011) | Primary care | Depression | I:106; C:102 | PHQ-9 (DS) | + | Weak |
Katon (2004) | Primary care | Diabetes patients, with depression | I:164; C:165 | PHQ-9 (DS) | + | Weak |
Carola Pèrez (2021) | Psychiatry | Depression | I:84; C:83 | PHQ-9 (DS) | ~ | Moderate |
Tirelli (2020) | Reumatology | Juvenile Idiopathic Arthritis, subtype Enthesitis-Related Arthritis | I:54; C:98, 51 | JADAS (DS), PROMIS physical function (DS), NRS pain (DS) | ~ | Moderate |
Buckley (2020) | Rheumatology | Juvenile Idiopathic Arthritis | I:97; C:NA | JADAS (DS), PROMIS physical function (DS), NRS pain (DS) | + | Moderate |
No feedback | ||||||
Baker (2023) | Dermatology | Eczema | I:147; C:149 | POEM (DS) | + | Moderate |
McCambridge (2007) | General public | University students | I:217; C:204 | AUDIT (DS) | + | Moderate |
Jaensson (2017) | General surgery | Various types of day surgery | I:513; C:514 | SwQoR (DS) | + | Strong |
Screening | ||||||
Frasure-Smith (1997) | Cardiology | Myocardial infarction | I:692; C:684 | GHQ (DS) | ~ | Strong |
Kronish (2020) | Cardiology | Myocardial infarction | I:499, 501; C:500 | PHQ-8 (DS) | ~ | Weak |
Allen (2011) | Community care | War veterans | I:97; C:NA | DASS (DS), AUDIT (DS) | + | Weak |
van der Zee-van den Berg (2017) | Midwife care | Mothers who just gave birth | I:1843; C:1246 | EPDS (DS) | + | Moderate |
Ferrell (2021) | Oncology | Palliative cancer, undergoing a therapeutic clinical trial | I:239; C:240 | Distress Thermometer (DS), FACT-G (DS) | + | Weak |
Shyu (2013) | Orthopedic and trauma surgery | Hip fracture patients | I:99; C:101, 99 | GDS short form (DS) | + | Strong |
Mallen (2017) | Primary care | Hip or knee osteoarthritis patients | I:1339; C:703 | GAD-2 (DS), PHQ-2 (DS), NRS pain (DS) | - | Moderate |
Fortmann (2020) | Primary care | Diabetes patients | I:236;C:239 | PHQ-9 (DS) | + | Moderate |
Rollman (2021) | Cardiology | Heart failure | I:251; C:252, 126 | PHQ-2 and -9 (DS) | + | Moderate |
Regueiro (2019) | Gastroenterology | IBS | I:322; C:NA | Harvey-Bradshaw Index (DS) for CD or Ulcerative Colitis Activity Index for UC, Short Inflammatory Bowel Disease questionnaire (DS), PHQ-9 (DS), GAD-7 (DS) | + | Moderate |
Howell (2020) | Oncology | Various types of cancer | I:13,260, 10,875; C:57,594, 48,068 | ESAS (DS), DART (DS), BPI (DS), CFS (DS), GAD (DS), PHQ (DS), occasionally the CPC (DS) or SDI (DS) | + | Strong |
Wylde (2022) | Orthopedics | Received knee replacement surgery | I:242; C:121 | BPI (DS), HADS (DS), PainDETECT (DS), Douleur Neuropathique 4 (DS) | + | Weak |
Buxton (2012) | Primary care | Low income and uninsured | I:36; C:81 | SF-12 (GEN), AUDIT (DS), PHQ-9 (DS) | ~ | Moderate |
Wu (2018) | Primary care | Diabetes type 2 | I:366, 380; C:341 | PHQ -2 and/or -9 (DS) | + | Strong |